Explore Cell Therapy

By: National Marrow Donor Program/Be The Match
  • Summary

  • In Explore Cell Therapy, we dig into the latest cell and gene therapy research and best practices to help you advance care for patients with hematologic malignancies and disorders. You’ll hear interviews with well-known and up-and-coming physicians in the hematopoietic stem cell transplantation (HCT) and cell and gene therapy field. You’ll receive insights from the National Marrow Donor Program®/Be The Match® and our partners into what it takes to connect patients to the best available therapies. In season 2, we examine practice-changing research and hot topics in HCT and other cellular therapies. You’ll hear conversations with experts who specialize in HCT and at community hematology/oncology practices.
    Copyright 2021 All rights reserved.
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • 13 - Optimizing Donor Searches in HCT, Part II: Overcoming Barriers
    Nov 20 2024

    This two-part “Explore Cell Therapy” podcast episode dives into recent research on the benefits and challenges of optimizing donor searches for allogeneic hematopoietic cell transplant (HCT). Joseph Pidala, MD, PhD, Moffitt Cancer Center, and Jason Dehn, MPH, NMDPSM, review crucial findings from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 1702 trial to shed light on the pivotal role of search prognosis in helping more eligible patients receive HCT.

    In Part II: Overcoming Barriers, the experts review implications for the future of donor search optimization, transplant access and health equity in an increasingly diverse patient population.

    To read bios on the panelists and to access additional resources related to this episode, visit Our Site.

    Show more Show less
    26 mins
  • 13 - Optimizing Donor Searches in HCT, Part I: Strategies and Considerations
    Nov 20 2024

    This two-part “Explore Cell Therapy” podcast episode dives into recent research on the benefits and challenges of optimizing donor searches for allogeneic hematopoietic cell transplant (HCT). Joseph Pidala, MD, PhD, Moffitt Cancer Center, and Jason Dehn, MPH, NMDPSM, review crucial findings from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 1702 trial to shed light on the pivotal role of search prognosis in helping more eligible patients receive HCT.

    In Part I: Strategies and Considerations, the experts discuss strategies to prioritize alternative donor sources to ensure that more patients receive HCT at optimal timepoints.

    To read bios on the panelists and to access additional resources related to this episode, visit Our Site.

    Show more Show less
    26 mins
  • 12 - Streamlining HCT Referrals, Part I: Overcoming Barriers through Coordinated Care
    Aug 12 2024

    In this two-part episode, Jonathan Fish, MD, with Cohen Children’s Medical Center and Joanna Pierro, DO, with Staten Island University Hospital discuss the transformative impact of a streamlined referral process to simplify setting up consultations for HCT and cell therapy.

    In Part I: Overcoming Barriers through Coordinated Care, guests explore how this simple system created using RedCap software can help overcome logistical barriers and enhance coordinated care through a single point of entry for referrals.

    To read bios on the panelists and to access additional resources related to this episode, visit Our Site.

    Show more Show less
    27 mins

What listeners say about Explore Cell Therapy

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.